High End Cellomics

Fastest growing segment fueling the growth of High End Cellomics Market


The global High End Cellomics Market is estimated to be valued at US$ 3.9 Bn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview: –

High end cellomic techniques help analyze biological processes and cellular behaviors at single cell level. Techniques like virtual single cell analysis provide high resolution and high content insights on individual cells, better understanding of cellular complexities and heterogenous cell populations.

Market key trends: –

One of the key trends driving the market growth is the increasing application of virtual single cell analysis technique for drug discovery and precision medicine. This technique involves computational modeling to study single cells without having to physically isolate them. It enables analysis of large number of cells, provides statistical power to rare cell detection compared to conventional methods. This trend is expected to significantly drive the demand for high end cellomics solutions in pharmaceutical and diagnostic sectors over the forecast period.

Segment Analysis: –

The high end cellomics market is dominated by instruments sub segment which holds around 55% market share. This is because instruments such as flow cytometers, next generation sequencing platforms, microscopes, cell sorters etc are essential tools for carrying out high throughput screening, cell analysis and understanding cell biology at single cell level.

Key Takeaways: –

The Global High End Cellomics Market Size is expected to witness high growth, exhibiting CAGR of 12% over the forecast period, due to increasing focus on precision medicine and stem cell research.

Regional Analysis: –

North America dominates the high end cellomics market with over 40% share owing to heavy investments in research and presence of major players in the US. Asia Pacific is the fastest growing region due to increasing research expenditures and focus on development of indigenous diagnostic and screening technologies in countries like China and India.

Key Players: –

Key players operating in the high end cellomics market are Thermo Fisher Scientific, Danaher, PerkinElmer, BD, Bio-Rad Laboratories, Agilent Technologies, Illumina, Luminex, Merck KGaA, GE Healthcare, Bruker, Nanostring Technologies, 10x Genomics, Fluidigm. Thermo Fisher and BD are the market leaders due to their broad product portfolio and strong geographical presence across major markets.

1.  Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it